Devising an Appropriate Control Group in a Study of Acupuncture and
Stroke Rehabilitation
Objective. To rigorously evaluate the efficacy of acupuncture for stroke rehabilitation. Method. Reviewed the randomized controlled clinical trials evaluating the efficacy of acupuncture and designed a study to address the challenge of placebo control. Results. Eight of nine randomized trials have shown that acupuncture treatment appears to benefit stroke recovery. However, these studies have not adequately controlled for the placebo response, so it is not clear whether the acupuncture treatment itself specifically treats post-stroke paralysis. The challenge of controlling for placebo responses is that while the patients can be blinded to experimental conditions, the acupuncturists can not. Accordingly, this study of acute stroke patients maintains the therapist's intent to heal, but directs the attention in a control group to the co-morbid problem of insomnia. Using procedures to maintain double blinding (of patient and outcome assessor), stroke patients receiving standard stroke rehabilitation therapy are randomized to three groups:
1. Acupuncture designed to treat paralysis, 2. Acupuncture designed to treat insomnia, and 3. No acupuncture treatment.
The hypothesis is that a treatment specific for paralysis will have a significantly better outcome than a treatment not specific to paralysis, for example, a treatment for insomnia.
Conclusions. There is a logical alternative to &dquo;sham&dquo; or &dquo;placebo&dquo; acupuncture control groups which preserves the acupuncturist's intention to benefit the patient, and tests the specific effects of acupuncture treatments for post-stroke paralysis. The validity of this model is being tested in an ongoing pilot study. HOWARD 
Developing an Integrative Medicine Research Agenda
Despite widespread use of complementary and alternative medicine (CAM) by patients in the United States, most conventionally trained clinicians remain relatively uninformed and/or resistant to CAM practices. Skepticism is based largely on the notion that the distinction between conventional and unconventional care is the base of evidence. However, much of conventional care also fails to meet the prevailing standards of evidence; unsubstantiated care is not unique to CAM. There is a clear need for the cultivation of rigorous research that will serve to identify optimal interventions for specific indications, regardless of whether they have historically been considered conventional or alternative. Such a research program has been implemented in the newly created Integrative Medicine Center (IMC) at the Griffin Hospital, in Derby, CT, a Yale-affiliated community hospital, home to both the IMC and the CDC-funded Yale-Griffin Prevention Research Center. The IMC provides patients dual evaluation by allopathic and naturopathic physicians, with referral to a panel of providers spanning conventional and CAM services as indicated. Panel members assist in the systematic data capture necessary for outcomes evaluation.
